Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study led by Professor Sallie Lamb of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford University and the University of Warwick, is due to be published in The Lancet today, and shows a tailored hand exercise programme improves function and quality of life for patients living with Rheumatoid Arthritis (RA).

RA affects more than 400,000 people in the UK, of whom about 80% have hand and wrist problems, and this has a substantial impact on quality of life, function and productivity. The new strengthening and stretching exercise programme developed for the study is a worthwhile, low cost intervention to adopt alongside medication.

The Strengthening And Stretching For Rheumatoid Arthritis of the Hand (SARAH) trial evaluated the effectiveness and cost-effectiveness of adding an individually tailored, progressive exercise programme for the hands and upper limbs in addition to usual care.

Approximately 80% of the patients using the SARAH programme alongside their medication, reported improvement of hand function a year after starting the programme. Significant improvements in strength and dexterity were also seen for patients performing the exercise programme.

Mark Williams, Research Fellow at NDORMS, says: “Current best practice mandates medication regimens, which substantially improve control of disease activity and joint damage, but don’t always impact on disability and health related quality of life. By adding an optimised exercise programme for hands and upper limbs to usual care for patients with RA, we can addresses key issues of this debilitating condition to help patients in their daily lives.”

Professor Karen Middleton, chief executive of the Chartered Society of Physiotherapy, added: “This study demonstrates the significant improvement physiotherapy can make to the quality of life of people with long-term conditions. Growing numbers of people are living with at least one of these conditions, so new interventions such as this will be invaluable as the NHS looks to address that rising demand within restrained budgets. This proactive approach enables people to manage their own condition and lead full and active lives while cutting costs for the NHS and social care.”

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.